Cartesian Therapeutics, Inc.
RNAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$77 | -$220 | $35 | -$26 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$19 | -$21 | $2 |
| Stock-Based Comp. | $7 | $23 | $11 | $8 |
| Change in WC | -$6 | $5 | -$60 | -$48 |
| Other Non-Cash | $52 | $159 | $2 | $2 |
| Operating Cash Flow | -$24 | -$51 | -$32 | -$60 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $7 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$34 | -$32 |
| Inv. Sales/Matur. | $0 | $28 | $20 | $16 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$9 | $35 | -$15 | -$17 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$27 | $0 | $0 |
| Stock Issued | $124 | $0 | $39 | $52 |
| Stock Repurch. | $0 | -$6 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $44 | $20 | $0 | $1 |
| Financing Cash Flow | $168 | -$13 | $39 | $53 |
| Forex Effect | -$0 | -$0 | $0 | -$0 |
| Net Chg. in Cash | $136 | -$30 | -$7 | -$25 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78 | $108 | $115 | $140 |
| End Cash | $214 | $78 | $108 | $115 |
| Free Cash Flow | -$33 | -$51 | -$33 | -$61 |